Taysha Gene Therapies TSHA
NASDAQ TSHA
$4.78 -0.09 (-1.95%)
As of: Oct 1, 2026 · 3:42 PM EDT

Taysha Gene Therapies (TSHA) Other Non-Current Liabilities (2020 - 2026)

Updated

Taysha Gene Therapies (TSHA) recorded Other Non-Current Liabilities of $1.64 million in Q2 2026, up 17.6% from $1.4 million a year earlier and up 3.7% from the prior quarter.

Analysis

Taysha Gene Therapies (TSHA) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, Taysha Gene Therapies reported Other Non-Current Liabilities of $1.55 million, up 18.6% from FY2024.

  • Annual Other Non-Current Liabilities has a five-year compound annual growth rate of 28.1% (FY2020 to FY2025).
  • Across earlier years, Other Non-Current Liabilities came in at $1.31 million in FY2024 (-17.0%), $1.58 million in FY2023 (-61.8%), $4.13 million in FY2022 (+10.6%) and $3.74 million in FY2021 (+730.0%).
  • The Q2 2026 figure is the highest quarterly Other Non-Current Liabilities since Q3 2023.
  • On a year-over-year basis, Other Non-Current Liabilities has increased for five consecutive quarters, with an average decline of 2.1% over the last eight quarters.
  • Peak year-over-year performance for Other Non-Current Liabilities in the last five years was growth of 730.0% in Q4 2021, against a decline of 64.8% in Q2 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $1.58 million (Q1 2026), $1.55 million (Q4 2025) and $1.58 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Taysha Gene Therapies 1.58 Bn 1.58 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.64 Mn
Mar 31, 2026 1.58 Mn
Dec 31, 2025 1.55 Mn
Sep 30, 2025 1.58 Mn
Jun 30, 2025 1.40 Mn
Mar 31, 2025 1.20 Mn
Dec 31, 2024 1.31 Mn
Sep 30, 2024 1.36 Mn
Jun 30, 2024 1.38 Mn
Mar 31, 2024 1.50 Mn
Dec 31, 2023 1.58 Mn
Sep 30, 2023 3.83 Mn
Jun 30, 2023 3.92 Mn
Mar 31, 2023 4.00 Mn
Dec 31, 2022 4.13 Mn
Sep 30, 2022 3.93 Mn
Jun 30, 2022 3.48 Mn
Mar 31, 2022 3.50 Mn
Dec 31, 2021 3.74 Mn
Sep 30, 2021 3.02 Mn
API Access

Taysha Gene Therapies Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=TSHA&period=max&api_key=YOUR_API_KEY